This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Review of the Pharmacologic Management of Depression.

Michael E. Thase, M.D.; Maurizio Fava, M.D.; Mark Zimmerman, M.D.; and Larry Culpepper, M.D., M.P.H.

Published: March 15, 2006

Article Abstract

Click to enlarge page

Michael E. Thase, M.D., began his presentation by stating that remission can be defined as a virtually complete relief of symptoms; that is, a level of symptoms basically indistinguishable from that of someone who has never been depressed. In depression, remission is usually understood to mean the optimal level of improvement for the acute phase treatment of an episode of major depressive disorder. Being in remission means that the individual has been able to return to a normal level of social functioning.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Frontothalamic Circuit Abnormalities in Patients With Bipolar Depression and Suicide Attempts

To identify potential markers for suicide risk, this fMRI study looked at neural activity in bipolar depression...